Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
29,345,980
-
Share change
-
-5,700,067
-
Total reported value
-
$38,771,352
-
Price per share
-
$1.32
-
Number of holders
-
76
-
Value change
-
-$18,696,221
-
Number of buys
-
31
-
Number of sells
-
54
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q1 2022
As of 31 Mar 2022,
AVROBIO INC - COM (AVRO) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
29,345,980 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, BlackRock Inc., GMT CAPITAL CORP, FEDERATED HERMES, INC., JPMORGAN CHASE & CO, VANGUARD GROUP INC, Aisling Capital Management LP, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.